Insulin glulisine Subcutaneous and Perflutren Protein Type A
Determining the interaction of Insulin glulisine Subcutaneous and Perflutren Protein Type A and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
Generic Name: perflutren
Brand name: Definity, Optison
Synonyms: Perflutren, Perflutren Lipid Microspheres
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glulisine Subcutaneous-Perflutren protein type a microsphere Intravenous
- Insulin glulisine Subcutaneous-Perforomist
- Insulin glulisine Subcutaneous-Perforomist, Symbicort
- Insulin glulisine Subcutaneous-Pergolide
- Insulin glulisine Subcutaneous-Pergonal
- Insulin glulisine Subcutaneous-Peri-Colace
- Perflutren Protein Type A-Insulin human inhaled Inhalation
- Perflutren Protein Type A-Insulin human regular Injection
- Perflutren Protein Type A-Insulin inhalation
- Perflutren Protein Type A-Insulin isophane
- Perflutren Protein Type A-Insulin isophane and insulin regular
- Perflutren Protein Type A-Insulin lispro